by University of Geneva S100A9 suppresses diabetic ketogenesis via hepatic TLR4. A Scheme indicating the generation of RIP-DTR;Tlr4WT (n = 5), RIP-DTR;Tlr4WT; S100A9OE (n = 6), RIP-DTR;Tlr4KO; S100A9OE (n = 7) and RIP-DTR;Tlr4Liver; S100A9OE (n = 6) experimental groups. Adenoviral injections and HTVI were done 3 days before or the same day of the first DT injection, respectively. B Plasma insulin levels of mice at day 0...
